Cyclical stocks to lead earnings recovery when vaccines roll out

Singapore

TECH-heavy markets that rallied during the pandemic will soon give way to sectors that stand to gain from the potential cyclical recovery once vaccines roll out, said analysts.

In a recent media teleconference, Tan Min Lan, Asia-Pacific head of UBS's chief investment office said vaccines, which UBS expects to be rolled out by the second quarter of next year, will enable corporate earnings across most of the major regions globally to recover.